RE:RE:RE:RE:RE:Q1 Report DayOkay, so if you feel that the numbers below will provide DM with numbers close to last years revenue than what's the issue? Because I recall you constantly arguing throughout the year that covid was dead; that the revenue was dead. Whereas, I constantly argued that covid testing was not dead. So you should be absolutely thrilled to see those numbers, as it should beat all your expectations over the last year no matter what they are.
Any money DM gets from covid testing strengthens the company financially and will go towards supporting the costs of building out the other verticals for long-term sustainability of the company with more predictable and consistant revenue streams.
And why did you subjectively pick $6.7 million in AI contracts as the threshold for DM to have a successful Q1. At $3.7 million the AI contracts would already be up about 300-400% year-over-year for the quarter. Wouldn't that be considered growth?
swyint123888 wrote: This is why I raised my Q1 rev target
-
December 2021 resulted in a total of 14,202 Covid-19 tests
-
January 2022 resulted in a total of 19,446 Covid-19 tests
-
February 2022 resulted in a total of 23,655 Covid-19 tests
-
March 2022 resulted in a total of 25,333 Covid-19 tests
As you see Q1 tests are way more than Dec Q4 and we had around 6.5 million in revs in Q4 for covid with december coming in at 14,000 tests only, I'm assuming Oct and Nov are similar
So I'm now guessing 10-12 million for covid and a 3.7 for AI guarantee.......and I'm sure when Marshall tells us there are auto renew and NDA revs he's talking about a few million....so ya good chance we come in close to 19 like Q1 last year but the total won't matter as far as stock price goes unless the AI is over 6-7 million at least.....and they have to report net earnings this time, if they go 2 quarters in row at a loss who will really care about headline numbers....not me that's for sure